ICUI (ICU Medical) 1-Year Sharpe Ratio : 0.67 (As of Jun. 25, 2025)

View and export this data going back to 1992. Start your Free Trial

What is ICU Medical 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-06-25), ICU Medical's 1-Year Sharpe Ratio is 0.67.

Competitive Comparison of ICU Medical's 1-Year Sharpe Ratio

For the Medical Instruments & Supplies subindustry, ICU Medical's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ICU Medical's 1-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where ICU Medical's 1-Year Sharpe Ratio falls into.

Save Embed

;

Save Embed

;

ICU Medical 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

ICU Medical (NAS:ICUI) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

ICU Medical 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of ICU Medical's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ICU Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICU Medical Inc (NAS:ICUI) » Definitions » 1-Year Sharpe Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

951 Calle Amanecer, San Clemente, CA, USA, 92673

Website

https://www.icumed.com

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Executives

Christian B. Voigtlander	officer: Chief Operating Officer	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Elisha W Finney	director	C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
David C. Greenberg	director	951 CALLE AMANECER, SAN CLEMENTE CA 92887
Vivek Jain	director, officer: Chairman and CEO	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Daniel Woolson	officer: VP, GM-Infusion Capital	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Virginia Ruth Sanzone	officer: VP, General Counsel	951 CALLE AMANECER, SAN CLEMENTE CA 92673
George A Lopez	director, officer: Chairman, other: Chairman	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Smiths Group International Holdings Ltd	10 percent owner	C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB
Group Plc Smiths	10 percent owner	765 FINCHKEY ROAD, LONDON X0 00000
William Seeger	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Kolleen T Kennedy	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Robert S Swinney	director	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Laurie Hernandez	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Brian Michael Bonnell	officer: Chief Financial Officer	ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Scott E Lamb	officer: Controller	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673